Mimerigen, Inc.
Biotechnology company · Guilford, Connecticut, United States
Mimerigen, Inc. is a biotechnology company headquartered in Guilford, Connecticut, United States. Its earliest recorded incorporation is in 2024. It has reported private securities offerings to the US SEC, most recently $105,000 sold in a notice filed in 2024.
Mimerigen at a glance
What does Mimerigen do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $105,000 sold (2024).
Frequently asked questions about Mimerigen
Where is Mimerigen headquartered?
Mimerigen, Inc. is headquartered in Guilford, Connecticut, United States.
What does Mimerigen do?
Mimerigen, Inc. is a biotechnology company.
When was Mimerigen founded?
The earliest incorporation on record for Mimerigen, Inc. is in 2024, according to public company registers.
Similar companies
- Abbratech Inc.Guilford, Connecticut, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences